531 related articles for article (PubMed ID: 17557314)
21. Assessing cardiac and liver iron overload in chronically transfused patients with sickle cell disease.
Badawy SM; Liem RI; Rigsby CK; Labotka RJ; DeFreitas RA; Thompson AA
Br J Haematol; 2016 Nov; 175(4):705-713. PubMed ID: 27507431
[TBL] [Abstract][Full Text] [Related]
22. Transfusional iron overload in children with sickle cell anemia on chronic transfusion therapy for secondary stroke prevention.
Kwiatkowski JL; Cohen AR; Garro J; Alvarez O; Nagasubramanian R; Sarnaik S; Thompson A; Woods GM; Schultz W; Mortier N; Lane P; Mueller B; Yovetich N; Ware RE;
Am J Hematol; 2012 Feb; 87(2):221-3. PubMed ID: 22120913
[TBL] [Abstract][Full Text] [Related]
23. Longitudinal MRI and Ferritin Monitoring of Iron Overload in Chronically Transfused and Chelated Children With Sickle Cell Anemia and Thalassemia Major.
Aubart M; Ou P; Elie C; Canniffe C; Kutty S; Delos V; Graffigne C; de Montalembert M; Brousse V
J Pediatr Hematol Oncol; 2016 Oct; 38(7):497-502. PubMed ID: 27548334
[TBL] [Abstract][Full Text] [Related]
24. Ferritin trends do not predict changes in total body iron in patients with transfusional iron overload.
Puliyel M; Sposto R; Berdoukas VA; Hofstra TC; Nord A; Carson S; Wood J; Coates TD
Am J Hematol; 2014 Apr; 89(4):391-4. PubMed ID: 24347294
[TBL] [Abstract][Full Text] [Related]
25. Early iron reduction programme for thalassaemia patients after bone marrow transplantation.
Li CK; Lai DH; Shing MM; Chik KW; Lee V; Yuen PM
Bone Marrow Transplant; 2000 Mar; 25(6):653-6. PubMed ID: 10734300
[TBL] [Abstract][Full Text] [Related]
26. [Iron overload in sickle cell anemia : a study of 94 patients].
Hafsia R; Belakhal F; Ben Salah N; Gouider E; Elborgi W
Tunis Med; 2011 Jun; 89(6):548-52. PubMed ID: 21681718
[TBL] [Abstract][Full Text] [Related]
27. Nontransferrin-bound iron in transfused patients with sickle cell disease.
Inati A; Musallam KM; Cappellini MD; Duca L; Taher AT
Int J Lab Hematol; 2011 Apr; 33(2):133-7. PubMed ID: 21382180
[TBL] [Abstract][Full Text] [Related]
28. Veno-occlusive disease of the liver after allogeneic bone marrow transplantation in children with hematologic malignancies: incidence, onset time and risk factors.
Hasegawa S; Horibe K; Kawabe T; Kato K; Kojima S; Matsuyama T; Hirabayashi N
Bone Marrow Transplant; 1998 Dec; 22(12):1191-7. PubMed ID: 9894723
[TBL] [Abstract][Full Text] [Related]
29. Changes in hemostatic parameters in hepatic veno-occlusive disease following bone marrow transplantation.
Park YD; Yasui M; Yoshimoto T; Chayama K; Shimono T; Okamura T; Inoue M; Yumura-Yagi K; Kawa-Ha K
Bone Marrow Transplant; 1997 May; 19(9):915-20. PubMed ID: 9156266
[TBL] [Abstract][Full Text] [Related]
30. Orthotopic liver transplantation for life-threatening veno-occlusive disease of the liver after allogeneic bone marrow transplant.
Rapoport AP; Doyle HR; Starzl T; Rowe JM; Doeblin T; DiPersio JF
Bone Marrow Transplant; 1991 Nov; 8(5):421-4. PubMed ID: 1768978
[TBL] [Abstract][Full Text] [Related]
31. Study of serum hepcidin in hereditary hemolytic anemias.
El Beshlawy A; Alaraby I; Abdel Kader MS; Ahmed DH; Abdelrahman HE
Hemoglobin; 2012; 36(6):555-70. PubMed ID: 23088733
[TBL] [Abstract][Full Text] [Related]
32. Pancreatic iron loading in chronically transfused sickle cell disease is lower than in thalassaemia major.
Noetzli LJ; Coates TD; Wood JC
Br J Haematol; 2011 Jan; 152(2):229-33. PubMed ID: 21118197
[TBL] [Abstract][Full Text] [Related]
33. Unrelated donor bone marrow transplantation for beta-thalassemia major: an experience from China.
Feng Z; Sun E; Lan H; Zhang C; Li Q; Zhu W
Bone Marrow Transplant; 2006 Jan; 37(2):171-4. PubMed ID: 16273116
[TBL] [Abstract][Full Text] [Related]
34. Prevention of secondary stroke and resolution of transfusional iron overload in children with sickle cell anemia using hydroxyurea and phlebotomy.
Ware RE; Zimmerman SA; Sylvestre PB; Mortier NA; Davis JS; Treem WR; Schultz WH
J Pediatr; 2004 Sep; 145(3):346-52. PubMed ID: 15343189
[TBL] [Abstract][Full Text] [Related]
35. Allogeneic BMT for acute leukemia and chronic granulocytic leukemia in University Medical Centre Ljubljana-Slovenia.
Pretnar J
Bone Marrow Transplant; 1998 Dec; 22 Suppl 4():S71-2. PubMed ID: 9916641
[TBL] [Abstract][Full Text] [Related]
36. Iron overload in survivors of childhood leukemia after allogeneic hematopoietic stem cell transplantation.
Chotsampancharoen T; Gan K; Kasow KA; Barfield RC; Hale GA; Leung W
Pediatr Transplant; 2009 May; 13(3):348-52. PubMed ID: 18518909
[TBL] [Abstract][Full Text] [Related]
37. Protein C, protein S and antithrombin III levels in the course of bone marrow and subsequent liver transplantation due to veno-occlusive disease.
Salat C; Holler E; Göhring P; Poley S; Kolb HJ; Pihusch R; Reinhardt B; Krämling HJ; Haller M; Hiller E
Eur J Med Res; 1996 Nov; 1(12):571-4. PubMed ID: 9438165
[TBL] [Abstract][Full Text] [Related]
38. Iron overload in hematopoietic cell transplantation.
Majhail NS; Lazarus HM; Burns LJ
Bone Marrow Transplant; 2008 Jun; 41(12):997-1003. PubMed ID: 18438425
[TBL] [Abstract][Full Text] [Related]
39. Consequences and management of iron overload in sickle cell disease.
Porter J; Garbowski M
Hematology Am Soc Hematol Educ Program; 2013; 2013():447-56. PubMed ID: 24319218
[TBL] [Abstract][Full Text] [Related]
40. Liver iron content assessment by routine and simple magnetic resonance imaging procedure in highly transfused patients.
Rose C; Vandevenne P; Bourgeois E; Cambier N; Ernst O
Eur J Haematol; 2006 Aug; 77(2):145-9. PubMed ID: 16608501
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]